Charles E. Sheedy - 31 Dec 2019 Form 5 Insider Report for Nuo Therapeutics, Inc. (AURX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
5
Accepted by SEC
26 Apr 2022, 21:21:36 UTC
Next SEC filing
26 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Charles E. Sheedy
Filing notes and source

Key filing fact

Charles E. Sheedy filed Form 5 for Nuo Therapeutics, Inc. (AURX) on 26 Apr 2022.

Key facts

  • This page summarizes Charles E. Sheedy's Form 5 filing for Nuo Therapeutics, Inc. (AURX).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 26 Apr 2022, 21:21.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AURX transaction Derivative

Warrants to purchase Common Stock

Purchase

Transaction value
$0
Shares
+15,000
Change %
Price
$0.000000
Shares after
15,000
Date
15 Nov 2019
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,000
Exercise price
$0.4000
Footnotes
F1
AURX transaction Derivative

Warrants to purchase Common Stock

Purchase

Transaction value
$0
Shares
+150,000
Change %
+1000%
Price
$0.000000
Shares after
165,000
Date
06 Dec 2019
Ownership
Direct
Underlying class
Common Stock
Underlying amount
150,000
Exercise price
$0.4000
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Acquired in connection with Note Purchase Agreement dated as of November 15, 2019

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .